Published in Physician Law Weekly, August 23rd, 2006
Study 1: Monomeric APOBEC3G is catalytically active and has anti-HIV activity.
According to a study from the United States, "APOBEC3G (APO3G) is a cytidine deaminase that restricts replication of vif-defective human immunodeficiency virus type 1 (HIV-1). Like other members of the cellular deaminase family, APO3G has the propensity to form homo-multimers."
"In the current study," wrote S. Opi and colleagues at the U.S. National Institutes of Health, "we investigated the functional determinants for multimerization of human APO3G and studied the role of APO3G...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly